FMA
CPXX

FNY Managed Accounts’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

FNY Managed Accounts’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-25,100
Closed -$758K – 584
2016
Q2 		$758K Buy
+25,100
New +$509K 0.69% 29

FNY Managed Accounts's CPXX Position: Q3 2016 in Review

FNY Managed Accounts sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 25,100 shares — an estimated $758K sold.

FNY Managed Accounts first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $758K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • FNY Managed Accounts reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • FNY Managed Accounts sold 25,100 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $758K.
  • FNY Managed Accounts first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • FNY Managed Accounts's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $758K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on FNY Managed Accounts's 13F filing for Q3 2016, filed 18 Oct 2016.